In experimental models of MS (i.e., experimental autoimmune encephalomyelitis—EAE), the activation of SIRT1 was shown to reduce neuronal injury in brain, spinal cord, and retinal ganglion cells, preventing subsequent neurological deficit. Here, SIRT1 is linked to experimental autoimmune encephalomyelitis.